CELU: Rega marang dodolan Celularity Inc
The success of Celularity Inc. (CELU) is based on the efficacy of placental cells in treating inflammation. High competition in regenerative medicine and pressure from traditional therapy methods influence the price-to-sales ratio dynamics on the current GURU.Markets platform chart, where 1.10 reflects the latest metric value. Business stability is further supported by flawless biomaterial logistics that adhere to all temperature requirements.
Celularity Inc. (CELU) - rincian metrik lan laporan keuangan
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Celularity Inc.|CELU - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal celularity.com|CELU - Utang perusahaan|Rasio utang marang kapitalisasi buku Celularity Corp|CELU - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Celularity|Rasio jangkoan perantara celularity.com
- data bathi bisnis lan rasio investasi:
CELU - Bathi resik|Prakiraan bathi perusahaan Celularity Inc.|CELU - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep celularity.com|CELU - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Celularity Corp|CELU - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Celularity|CELU - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan celularity.com|CELU - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Celularity Inc.
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:Celularity Inc CELU
Fundamental asset screening begins by filtering market noise through dynamic metrics. This market cap-to-revenue ratio compares the total value of Celularity Inc. (CELU) with its sales volume, determining the premium paid per unit of revenue. Analyzing this indicator allows for an assessment of market expectations regarding the scaling of the allogeneic cell therapy platform. For Celularity Inc. (CELU), such a valuation is critical during its expansion into the oncology and immunopharmaceuticals segments.
Perusahaan pesaing
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|Protagonist Corp (PTGX) - Kapitalisasi marang pendapatan|IMVT: Multiplikator P/S|Rega marang dodolan kiniksa.com (KNSA)|Rasio rega marang pendapatan Grifols|Rasio rega marang pendapatan ADPT|Kapitalisasi marang pendapatan CLDX (Celldex)|Multiplikator P/S Aurinia Corp (AUPH)|Rasio rega marang pendapatan BioCryst BCRX|veratx.com - Rasio rega marang pendapatan|Dianthus Therapeutics, Inc. - Multiplikator P/S|PHVS - Multiplikator P/S|AbCellera Biologics Inc (ABCL) - Rasio rega marang pendapatan|Tourmaline - Rasio kapitalisasi pasar marang pendapatan|PGEN (Precigen, Inc.) - Multiplikator P/S|pharming.com (PHAR) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan NKTR (Nektar Therapeutics Inc.)|Kapitalisasi marang volume dodolan UPB|Zenas Biopharma, Inc. - Kapitalisasi marang pendapatan|Immunome Bio (IMNM) - Rega marang dodolan|GOSS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KALV (kalvista.com)|SEPN: Multiplikator P/S|PVLA - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Savara Corp|Rasio kapitalisasi marang pendapatan RIGL (Rigel Corp)|Multiplikator P/S ANAB|Kapitalisasi marang pendapatan astriatx.com ATXS|enGene - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan RAPT Therapeutics Inc. (RAPT)|Aerovate - Multiplikator P/S|Aclaris Therapeutics, Inc (ACRS) - Kapitalisasi marang pendapatan|KYTX: Multiplikator P/S|Rega marang dodolan tizianalifesciences.com (TLSA)|Rasio rega marang pendapatan Cabaletta Bio|Rasio rega marang pendapatan VTYX|Kapitalisasi marang pendapatan THTX (Theratechnologies Inc)|Multiplikator P/S Avalo Therapeutics Inc (AVTX)|Rasio rega marang pendapatan Eledon Pharmaceuticals ELDN|AGEN (agenusbio.com) - Rasio rega marang dodolan|Climb Bio - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ZURA (Zura Bio Ltd)|ATYR: Multiplikator P/S|Adagene Inc. (ADAG) - Multiplikator P/S|Rasio rega marang pendapatan ImageneBio|STTK: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Equillium, Inc. (EQ)|Kapitalisasi marang pendapatan connectbiopharm.com CNTB|Multiplikator P/S IMUX (Immunic)|Multiplikator P/S Atara Biotherapeutics, Inc. ATRA|IFRX: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan XFOR (x4pharma.com)|ACET: Multiplikator P/S|INMB - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Barinthus Bio|Kapitalisasi marang pendapatan Kezar Life Sciences Inc (KZR)|Rasio rega marang pendapatan SAB Biotherapeutics (SABS)|Kapitalisasi marang pendapatan akaritx.com AKTX|Enlivex Therapeutics Ltd. - Kapitalisasi marang pendapatan|Multiplikator P/S Q32 Bio Inc QTTB|GOVX - Rasio rega marang pendapatan|EDSA (Edesa Biotech Corp) - Rasio kapitalisasi marang pendapatan|IBIO: Multiplikator P/S|Rega marang dodolan Carisma Therapeutics Inc. (CARM)|XTLB (XTL Biopharmaceuticals Ltd.) - Multiplikator P/S|Kapitalisasi marang pendapatan Bolt Bio (BOLT)|Multiplikator P/S HCWB|APVO - Rega marang dodolan|Rasio rega marang pendapatan AIM ImmunoTech Inc. AIM|Aditxt Inc. - Rasio rega marang pendapatan|GRI: Kapitalisasi marang pendapatan|XRTX - Multiplikator P/S|ReShape Lifesciences (HIND) - Rasio rega marang pendapatan|REVB (Revelation Biosciences Corp) - Rasio rega marang pendapatan|INDP (Indaptus Therapeutics) - Multiplikator P/S|Multiplikator P/S scinai.com|Rasio rega marang pendapatan CalciMedica, Inc. (CALI)|AFMD (affimed.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos)|Koefisien rega marang pendapatan HOOKIPA Pharma, Inc. (HOOK)|IGMS: Kapitalisasi marang pendapatan|iteostherapeutics.com - Kapitalisasi marang volume dodolan|OCEA (Ocean Biomedical) - Kapitalisasi marang pendapatan|Rega marang dodolan TC BioPharm (Holdings) Plc (TCBP)|Kapitalisasi marang pendapatan THRD
